InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-33.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Sullivan John F, Directeur. Director active across 1 company, notably TransMedics Group, Inc.. Aggregated, 2 reports have been logged. Activity tracked since 30 August 2021. The latest transaction was filed on 30 August 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
3,200 shares@ US$0.280.0000% mcap50.0% of flowCommon StockSEC:0000899243-21-034767:0
3,200 shares@ US$0.2850.0% of flowCommon StockSEC:0000899243-21-034767
2 of 2 declarations
About Sullivan John F
John F. Sullivan is the Vice President of Quality & Engineering at TransMedics Group, Inc. He oversees operations related to quality and engineering, ensuring that products meet the highest standards. His expertise is essential in ensuring compliance and innovation.
